PSCH vs. LFSC
Compare and contrast key facts about Invesco S&P SmallCap Health Care ETF (PSCH) and F/m Emerald Life Sciences Innovation ETF (LFSC).
PSCH and LFSC are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. PSCH is a passively managed fund by Invesco that tracks the performance of the S&P SmallCap 600 Health Care Index. It was launched on Apr 7, 2010. LFSC is an actively managed fund by F/m Investments. It was launched on Oct 30, 2024.
Performance
PSCH vs. LFSC - Performance Comparison
Loading graphics...
PSCH vs. LFSC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
PSCH Invesco S&P SmallCap Health Care ETF | -6.60% | -0.49% | 2.19% |
LFSC F/m Emerald Life Sciences Innovation ETF | -4.45% | 56.54% | -6.02% |
Returns By Period
In the year-to-date period, PSCH achieves a -6.60% return, which is significantly lower than LFSC's -4.45% return.
PSCH
- 1D
- 5.03%
- 1M
- -5.05%
- YTD
- -6.60%
- 6M
- -1.10%
- 1Y
- -4.92%
- 3Y*
- -1.84%
- 5Y*
- -7.37%
- 10Y*
- 6.52%
LFSC
- 1D
- 6.16%
- 1M
- -3.82%
- YTD
- -4.45%
- 6M
- 17.66%
- 1Y
- 55.83%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
PSCH vs. LFSC - Expense Ratio Comparison
PSCH has a 0.29% expense ratio, which is lower than LFSC's 0.54% expense ratio.
Return for Risk
PSCH vs. LFSC — Risk / Return Rank
PSCH
LFSC
PSCH vs. LFSC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco S&P SmallCap Health Care ETF (PSCH) and F/m Emerald Life Sciences Innovation ETF (LFSC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PSCH | LFSC | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.21 | 1.93 | -2.14 |
Sortino ratioReturn per unit of downside risk | -0.14 | 2.65 | -2.79 |
Omega ratioGain probability vs. loss probability | 0.98 | 1.33 | -0.35 |
Calmar ratioReturn relative to maximum drawdown | -0.10 | 3.20 | -3.30 |
Martin ratioReturn relative to average drawdown | -0.23 | 8.96 | -9.19 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| PSCH | LFSC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.21 | 1.93 | -2.14 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.32 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.28 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.49 | 0.94 | -0.45 |
Correlation
The correlation between PSCH and LFSC is 0.74, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
PSCH vs. LFSC - Dividend Comparison
PSCH's dividend yield for the trailing twelve months is around 0.01%, while LFSC has not paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
PSCH Invesco S&P SmallCap Health Care ETF | 0.01% | 0.04% | 0.27% | 0.01% | 2.27% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.03% |
LFSC F/m Emerald Life Sciences Innovation ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
PSCH vs. LFSC - Drawdown Comparison
The maximum PSCH drawdown since its inception was -46.32%, which is greater than LFSC's maximum drawdown of -29.74%. Use the drawdown chart below to compare losses from any high point for PSCH and LFSC.
Loading graphics...
Drawdown Indicators
| PSCH | LFSC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -46.32% | -29.74% | -16.58% |
Max Drawdown (1Y)Largest decline over 1 year | -15.36% | -16.25% | +0.89% |
Max Drawdown (5Y)Largest decline over 5 years | -46.32% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -46.32% | — | — |
Current DrawdownCurrent decline from peak | -36.32% | -11.08% | -25.24% |
Average DrawdownAverage peak-to-trough decline | -13.26% | -8.25% | -5.01% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.77% | 5.80% | +0.97% |
Volatility
PSCH vs. LFSC - Volatility Comparison
The current volatility for Invesco S&P SmallCap Health Care ETF (PSCH) is 8.64%, while F/m Emerald Life Sciences Innovation ETF (LFSC) has a volatility of 10.35%. This indicates that PSCH experiences smaller price fluctuations and is considered to be less risky than LFSC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| PSCH | LFSC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.64% | 10.35% | -1.71% |
Volatility (6M)Calculated over the trailing 6-month period | 14.92% | 19.97% | -5.05% |
Volatility (1Y)Calculated over the trailing 1-year period | 23.58% | 29.24% | -5.66% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.91% | 29.31% | -6.40% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.65% | 29.31% | -5.66% |